# NEXT SESSION — BD Platform

**Written:** 2026-05-24 (Session 26)  
**Commit deployed:** `95dd91fa`

---

## Session 26 Summary

### ✅ Pharma Landscape Tab — Full Rebuild (Phases 2–4)

**Phase 2 — DB schema:**
- Added 8 new columns to `companies` table: `geography`, `revenue`, `r_and_d_spend`, `r_and_d_pct`, `ta_focus_1`, `ta_focus_2`, `last_enriched_at`, `market_cap_display`
- Backfilled all 35 ranking companies (15 China + 20 Global) with financial data + geography tags
- Fixed Pfizer data error (was `status='acquired'` with no `acquired_by`)

**Phase 3 — All Companies section:**
- New `Company Repository` block renders at top of `tab-pharma-intel` on tab enter
- Supabase-driven: all active companies with search/filter (geography, company_type)
- Columns: Company, Geography, Type, Mkt Cap, TA1, TA2, Drugs
- Click → `openCompanySlideOver()` dossier
- BD Focus filter = `geography IS NULL` (the 47 competitive pipeline companies)

**Phase 4 — Dossier buttons on ranking rows:**
- `_RANKING_ID_MAP` maps all 35 piToggle IDs to Supabase company IDs
- `_addRankingDossierBtns()` injects `Profile →` buttons on tab enter

**Audit docs written:**
- `docs/industry_landscape_audit.md`
- `docs/ownership_control_audit.md`

### ✅ Ownership Model — Schema + Frontend Wiring

**DB schema (drugs table):** 6 new columns:
- `current_owner_company_id` — controls which company row the drug appears under
- `originator_company_id` — who created the drug (identity anchor stays `company_id`)
- `ownership_status` — enum: `originated`, `licensed`, `acquired`, `partnered`, `optioned`
- `display_partner_name` — human-readable originator label for the partner pill
- `ownership_source_url` — press release / deal announcement URL
- `ownership_confidence_level` — enum: `confirmed`, `supported`, `inferred`

**Frontend:**
- `_makeAreaPI` + `tl1aPI._loadFromSupabase()`: both now use priority chain `current_owner_company_id || entity_id || company_id` for display grouping
- Acquired-status filter patched: drugs from acquired companies pass through when `current_owner_company_id` is set
- Partner pill renders `display_partner_name` for acquired/licensed drugs

---

## What Still Needs to Happen

### 🔴 P0 — UCB/Candid Data Backfill (the point of the ownership model)

The schema is live but CND drugs have not been patched yet. Run this SQL against Supabase:

```sql
-- Step 1: Mark Candid as acquired by UCB
UPDATE companies
SET status = 'acquired', acquired_by = 'ucb'
WHERE id = 'candid';

-- Step 2: Roll all CND drugs under UCB's row
UPDATE drugs
SET
  current_owner_company_id   = 'ucb',
  originator_company_id      = 'candid',
  ownership_status           = 'acquired',
  display_partner_name       = 'Candid Therapeutics',
  ownership_source_url       = 'https://www.ucb.com/stories-from-ucb/ucb-acquires-candid-therapeutics',
  ownership_confidence_level = 'confirmed'
WHERE company_id = 'candid';
```

After this patch: cizutamig, cnd319, cnd460 should render under UCB's row in the TCell and Autoimmune tabs, with a "Candid" originator pill.

**Verify by checking the TCell and Autoimmune area tabs — UCB should show 3 additional CND drugs, and no Candid Therapeutics row should appear.**

### 🟡 P1 — licensed_in Drug Backfill (optional, incremental)

The 12 drugs with `partnership_type='licensed_in'` or `co_developed` can be backfilled into the new ownership fields for consistency. Canonical examples from the audit doc:

| Drug | current_owner | ownership_status |
|---|---|---|
| atg-201 (UCB/Antengene) | ucb | licensed |
| SIM0709 (BI/Simcere) | boehringer | licensed |
| afimkibart (Roche/Telavant) | roche | acquired |
| tulisokibart (Merck/Prometheus) | merck | acquired |

Not urgent — `entity_id` still works for these. Do when convenient.

### 🟡 P2 — Company Repository UX Polish

The All Companies section is functional but could be improved:
- Area tab counts: show which areas each company appears in as colored chips
- Sort: add column-header click sorting (currently sorts by drug count desc)
- Geography display: BD Focus companies show no geography pill — add a subtle "BD" tag

### 🟡 P3 — Pharma Landscape Rankings → Full Supabase Drive

Currently: hardcoded HTML rows + injected dossier buttons
Future: render ranking rows from Supabase via JS (like All Companies)
- Constraint: preserve `pi-dr-row` editorial detail blocks in place
- Approach: keep detail HTML, replace only the summary `<tr>` data source
- Not urgent until ranking data needs to be updated frequently

### 🟡 P4 — Pending from earlier

- **Task #92** (pending): Add `risk_summary` and `bd_angle` to `company_profiles` schema + backfill TL1A

---

## Key Architecture Notes

- `current_owner_company_id` WINS for display grouping; `company_id` is the identity anchor (never changed)
- `entity_id` preserved for backward compatibility; `current_owner_company_id` takes precedence
- Future acquisitions: set `current_owner_company_id` + `originator_company_id` + `ownership_status` + mark `companies.status='acquired'` — no frontend changes needed
- Geography `null` = BD Focus (competitive pipeline companies); `'china'` / `'global'` = ranking table companies
- `market_cap_display` (text) for approximate strings like "~$60B"; `market_cap` (bigint) for live stock price data

---

## Validation

893/893 ground truth tests passing at close of session.
